Global Oncology Devices Market Outlook 2024, Forecast To 2033
17 Jan, 2024
The oncology devices market has exhibited rapid growth, escalating from $128.46 billion in 2023 to $153.93 billion in 2024, with an impressive 19.8% CAGR. Historical growth is attributed to the rising prevalence of cancer, an aging population, increased demand for personalized cancer treatments, and genomic profiling. The market is anticipated to see rapid growth, reaching $298.31 billion in 2028, driven by minimally invasive surgical techniques, biodegradable implants, global healthcare expansion, value-based care models, and digital health integration. Key trends include advancements in radiation therapy, early detection technologies, oncology device advancements, liquid biopsies, and AI-powered decision support.
Global Oncology Devices Market Key Driver
A growing number of cancer cases globally boosts the demand for oncology devices. Cancer ranks as the second leading cause of death in the USA, with prostate, lung, bowel, and female breast cancer accounting for 43% of new cases in 2021. The increasing incidence of cancer fuels the demand for oncology devices to treat patients.
Get A Free Sample Of The Global Oncology Devices Market ReportGlobal Oncology Devices Market Segments
The oncology devices market covered in this report is segmented –
1) By Device Type: Brachytherapy Devices, Endoscopic Devices
2) By Therapy: Chemotherapy, Hormone Therapy, Biotherapy/Immunotherapy, Radition Therapy
3) By End User: Hospitals, Cancer Research Institutes, Other End Users
By Geography: The regions covered in the oncology devices market report are Asia-Pacific, Western Europe, Eastern Europe,North America, South America, Middle East, and Africa. Among these regions
North America was the largest region in the oncology devices market in 2023. Asia-Pacific was the second-largest region in the oncology devices market report. The regions covered in the oncology devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
Major Oncology Devices Industry Players
Eckert & Ziegler BEBIG GmbH, Oncura Inc., GE Healthcare, Medtronic plc, Varian Medical Systems Inc., Elekta AB, Theragenics Corporation, Accuray Incorporated, Roche Diagnostics, IBA Group, Biogenex Laboratories, Becton Dickinson and Company, Siemens Healthineers, Philips Healthcare, Hologic Inc., IBA AG, ViewRay Inc., Canon Medical Systems Corporation, Brainlab, PerkinElmer, RaySearch Laboratories, Mevion Medical Systems, Vision RT, IsoRay, RefleXion Medical, Alpha Tau Medical, Nanobiotix, Mirada Medical Ltd., Navidea Biopharmaceuticals Inc.
Get The Full Global Oncology Devices Market Report
Oncology Devices Market Overview
Oncology devices are medical devices used in the diagnosis, management, and treatment of cancer.
Oncology Devices Global Market Report 2023 provides data on the global oncology devices market such as market size, growth forecasts, segments and geographies, competitive landscape including leading competitors’ revenues, profiles and market shares. The oncology devices market report identifies opportunities and strategies based on market trends and leading competitors’ approaches.